High-affinity T cell receptor ImmTAC® bispecific efficiently redirects T cells to kill tumor cells expressing the cancer-testis antigen PRAME
高亲和力 T 细胞受体 ImmTAC® 双特异性有效重定向 T 细胞以杀死表达癌睾丸抗原 PRAME 的肿瘤细胞
期刊:Immunotherapy Advances
影响因子:4.1
doi:10.1093/immadv/ltae008
Ana R Ribeiro, Camille Britton-Rivet, Laura Collins, Ricardo J Carreira, Sylvie Moureau, Adel Benlahrech, Sarah Stanhope, Stephen Harper, Nathaniel Liddy, Tara M Mahon, Kristina Petrovic, Mark Fife, David Depoil, Philip Addis, Nicole Bedke, Lucie Bouard, Ronan O'Dwyer, Duncan Gascoyne, Koustubh Rana
